- A prospective clinical trial reported in Aging claims that 60 daily hyperbaric oxygen therapy (HBOT) sessions significantly lengthened telomeres and reduced senescent T-cells in isolated peripheral blood mononuclear cells, positioning HBOT as a potential anti-aging intervention.  
- Participants questioned the statistical rigor of the HBOT paper, noting that the reported error bars are nearly as large as the measured effect sizes, casting doubt on the biological significance of the findings.  
- The discussion linked to Henshaw Hyperbaric Chambers (henshawhyperbarics.co.uk) as a commercial source of soft-shell HBOT systems, prompting debate over whether pressurized oxygen confers advantages beyond high-flow oxygen masks.  
- 91lib.com was identified as a Chinese “scihub-like” shadow library that mirrors Sci-Hub content; speculation centered on its operation as a reputation-driven PHP forum (“BBS”) where users accrue virtual points for uploading requested papers.  
- Cerebras’ wafer-scale CS-1 processor was highlighted for achieving the first real-time simulation of over one million computational fluid-dynamics cells faster than physical time, enabling predictive modeling of power-plant behavior ahead of actual events.